Abstract:Severe fever with thrombocytopenia syndrome (SFTS) is a widespread infectious disease with high mortality. Hence, identifying valuable biomarkers for detecting the early changes in SFTS is crucial. In this study, we investigated the relationship between the difference in hematocrit (HCT) and serum albumin (ALB) levels (HCT‐ALB) and the prognosis of patients with SFTS virus infection. After excluding the patients who did not meet the SFTS diagnostic criteria, those with SFTS from the First Affiliated Hospital of Wannan Medical College were divided into a fatal and Nonfatal group based on their disease prognosis. A dynamic analysis of the daily laboratory data was conducted for 14 days following SFTS onset. A receiver operating characteristic (ROC) curve was used to evaluate the predictive value of HCT‐ALB. Another sample of patients with SFTS admitted to the First Affiliated Hospital of Nanjing Medical University was utilized to verify the study conclusions. A total of 158 patients with SFTS were included. Among them, 126 patients were categorized in the Nonfatal group and 32 in the fatal group, leading to a mortality rate of 20.25% (32/158). Univariate analysis of the laboratory test findings and ROC curve analysis showed that alanine aminotransferase (ALT), aspartate aminotransferase (AST), HCT‐ALB, and lactate dehydrogenase (LDH) had a relatively better ability to discriminate the disease condition of the patients with SFTS. Moreover, HCT‐ALB served as a predictor of SFTS prognosis. Additionally, an area under the ROC curve (AUC) of 0.777 and a critical HCT‐ALB value of 4.75 on day 7 were associated with a sensitivity of 83.3% and a specificity of 73.9%. On day 8 (AUC = 0.882), the critical value of HCT‐ALB was 9.25, while the sensitivity was 100% and specificity was 76.5%. Further verification based on the data of 91 patients with SFTS admitted to the First Affiliated Hospital of Nanjing Medical University demonstrated a mortality rate of 51% (24/47) among those with HCT‐ALB values >4.75 on day 7 of the disease course, highlighting the potential of the HCT‐ALB value of >4.75 for predicting SFTS prognosis. High HCT‐ALB values are closely related to the mortality of patients with SFTS. HCT‐ALB is a sensitive and independent predictor of early disease in patients with SFTS.

Construction of an early differentiation diagnosis model for patients with severe fever with thrombocytopenia syndrome and hemorrhagic fever with renal syndrome

Correlations between clinical features and death in patients with severe fever with thrombocytopenia syndrome.

Prediction of prognosis in patients with severe fever with thrombocytopenia syndrome

Comparison of epidemiological characteristics between hemorrhagic fever with renal syndrome patients and severe fever with thrombocytopenia syndrome patients

A Scoring Model for Predicting Prognosis of Patients with Severe Fever with Thrombocytopenia Syndrome

A model based on meta-analysis to evaluate poor prognosis of patients with severe fever with thrombocytopenia syndrome

Development and validation of a clinical risk score to predict the occurrence of critical illness in hospitalized patients with SFTS

Early Warning Models for Predicting Severity in Febrile and Nonfebrile Stages of Hemorrhagic Fever with Renal Syndrome

Application of a decision tree model in the early identification of severe patients with severe fever with thrombocytopenia syndrome

Fatal patients with severe fever with thrombocytopenia syndrome in China

Clinical features of severe fever with thrombocytopenia syndrome and analysis of risk factors for mortality

Clinical value of coagulation parameters in predicting the severity of severe fever with thrombocytopenia syndrome

Construction and validation of a dynamic nomogram using Lasso-logistic regression for predicting the severity of severe fever with thrombocytopenia syndrome patients at admission

Risk factors of severe fever with thrombocytopenia syndrome combined with central neurological complications: A five-year retrospective case–control study

A nomogram and heat map based on LASSO‐Cox regression for predicting the risk of early‐stage severe fever with thrombocytopenia syndrome patients developing into critical illness at 7‐day and 14‐day

A nomogram to predict mortality in patients with severe fever with thrombocytopenia syndrome

Concurrent Measurement of Dynamic Changes in Viral Load, Serum Enzymes, T Cell Subsets, and Cytokines in Patients with Severe Fever with Thrombocytopenia Syndrome

The clinical and immunological characteristics in fatal severe fever with thrombocytopenia syndrome virus (SFTSV) infection

Identification of severe fever with thrombocytopenia syndrome virus isolates in the northwest of Hubei Province, China

Severe fever with thrombocytopenia syndrome: a systematic review and meta-analysis of epidemiology, clinical signs, routine laboratory diagnosis, risk factors, and outcomes

Difference in hematocrit and plasma albumin levels as an early biomarker of severity and prognosis in patients with severe fever and thrombocytopenia syndrome